(Q34529081)

2 August 2017

title

Atypical antipsychotics and pituitary tumors: a pharmacovigilance study (English)

1 reference

2 August 2017

Ana Szarfman

1

1 reference

2 August 2017

Joseph M Tonning

series ordinal

2

1 reference

2 August 2017

Jonathan G Levine

series ordinal

3

1 reference

2 August 2017

P Murali Doraiswamy

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

26

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

748-758

1 reference

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Physical health monitoring of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

The effect of atypical antipsychotic agents on prolactin levels in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Dopamine antagonists and the development of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Diagnostic and therapeutic approach to pituitary incidentalomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Hyperprolactinemia: pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Pharmacovigilance in the 21st century: new systematic tools for an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Perspectives on the use of data mining in pharmaco-vigilance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

A Bayesian neural network method for adverse drug reaction signal generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

[Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System]: Discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Pituitary size in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2*A1 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

Control of lactotrop proliferation by dopamine: essential role of signaling through D2 receptors and ERKs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.748

21 January 2018

Identifiers

DOI

10.1592/PHCO.26.6.748

1 reference

2 August 2017

1 reference